NITA RASTOGI: Open Payments
NPI 1306827092 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 91 payments from 20 companies in 2025. Trend: 2023 $1,597 · 2024 $1,837 · 2025 $1,722
Food & beverage: $1,722
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $341 |
| ABBVIE INC. | 13 | $217 |
| AstraZeneca Pharmaceuticals LP | 11 | $198 |
| Braeburn Inc. | 3 | $157 |
| Corcept Therapeutics | 11 | $146 |
| Lilly USA, LLC | 9 | $139 |
| Exact Sciences Corporation | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $75 |
| SHIELD THERAPEUTICS INC | 1 | $59 |
| IBSA Pharma Inc. | 3 | $57 |
Products named: Wegovy, BRIXADI, Korlym, JARDIANCE, UBRELVY, VRAYLAR, AIRSUPRA, FARXIGA.
Industry payments across PA — which companies pay providers there.
